A formal model for analyzing drug combination effects and its application in TNF-α-induced NFκB pathway
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background: Drug combination therapy is commonly used in clinical practice. Many methods including Bliss independence method have been proposed for drug combination design based on simulations models or experiments. Although Bliss independence method can help to solve the drug combination design problem when there are only a small number of combinations, as the number of combinations increases, it may not be scalable. Exploration of system structure becomes important to reduce the complexity of the design problem. Results: In this paper, we deduced a mathematical model which can simplify the serial structure and parallel structure of biological pathway for synergy evaluation of drug combinations. We demonstrated in steady state the sign of the synergism assessment factor derivative of the original system can be predicted by the sign of its simplified system. In addition, we analyzed the influence of feedback structure on survival ratio of the serial structure. We provided a sufficient condition under which the combination effect could be maintained. Furthermore, we applied our method to find three synergistic drug combinations on tumor necrosis factor α-induced NFκB pathway and subsequently verified by the cell experiment. Conclusions: We identified several structural properties underlying the Bliss independence criterion, and developed a systematic simplification framework for drug combiation desgin by combining simulation and system reaction network topology analysis. We hope that this work can provide insights to tackle the challenging problem of assessment of combinational drug therapy effect in a large scale signaling pathway. And hopefully in the future our method could be expanded to more general criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Serial structure. The left subfigure illustrate the general serial structure. The right subfigure is an example from [1]. The shaded areas are the simplified systems. Based on the simplification rules the virtual inhibitors on the simplified systems in this example target on the reaction B-P+C→C-P (or it also could be seen as target on component B-P) and component C.](https://figures.cochat.ai/paper-figures/b5d9f451157b44a69ec9a4650ffc07f4/a-formal-model-for-analyzing-drug-combination-effects-and-its-application-in-tnf-figure-1.jpg)
![Figure 2 Parallel structure. The left subfigure illustrate the general parallel structure. The right subfigure is an example from [1]. The shaded areas are the simplified systems. Based on the simplification rules the virtual inhibitors on the simplified systems in this example target on the reactions B1-P+C→C-P (or it also could be seen as target on component B1-P) and B2-P+C→C-P (or target on component B2-P).](https://figures.cochat.ai/paper-figures/5e7988e233684b919f9a0b2c5e70dae3/a-formal-model-for-analyzing-drug-combination-effects-and-its-application-in-tnf-figure-2.jpg)

![Figure 4 S curves of Figure 1 and 2. In the simulation, we adopted the same doses of both inhibitors like [1]. The left subfigure is the simulation results of the serial structure in Figure 1. The right subfigure is the simulation results of the parallel structure in Figure 2. The S curves of original systems are in red. The blue curves are the S curves recovered from the results of simplified systems based on Lemma 1 and the two corollaries. In fact the S curve of the simplified serial system has opposite sign to that of the original serial system. Obviously the S curves recovered agreed with the original S curves. The signs of S curves are negative showing the synergistic effect of the serial and parallel structures. In left subfigure the absolute values of S are much small (10-3 order) to those of the S in right subfigure (10-1 order). Combination therapy of the parallel structure could be more effective. These results are conincident with the results in [1].](https://figures.cochat.ai/paper-figures/727b19f4a8264d8791bb70ca60900710/a-formal-model-for-analyzing-drug-combination-effects-and-its-application-in-tnf-figure-4.jpg)
![Figure 5 Negative feedback structure. This system with negative feedback loop (from [1]) is constructed based on the serial system in Figure 1 by adding a feedback loop (orange color) which is from the output C-P to the activation of B to the serial structure. The output of this system is still the concentration of activation C.](https://figures.cochat.ai/paper-figures/264c6a474feb48f6bb4ea057eef506ef/a-formal-model-for-analyzing-drug-combination-effects-and-its-application-in-tnf-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“If both compounds have similar mechanisms of action or affect the same cellular pathway, the model may not detect true synergy, although a reduction in cell viability is observed [38].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Bliss Independence model predicts the combination of effects based on the probability that both compounds act separately and that their effects are independent.”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [38]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As a result, it could be responding more sensitively to the cumulative damage caused by 5‐fluorouracil, especially [38, 39].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a clinical context, this increase could lead to an inflammatory response and additional tissue damage, which contrasts with the less inflammatory (and more controlled) apoptosis [38, 39, 40].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 1×
“Inspired by the Combination Index theorem offered by Chou-Talalay [10,11], here we introduce an operational concept, "Synergism Assessment Factor", for addressing the interaction of drug combination.”
MethodJaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Drug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739 · cited 2×
“Since Bliss model is relatively simple and still widely used by some researchers recently [16-18], we start our studies from this simple model and operationally provide a combination effect assessment index inspired by the Combination Index theorem [10-12].”
MethodChou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
Hoffmann, A., Levchenko, A., Scott, M. L., & Baltimore, D. (2002) · Science · doi:10.1126/science.1071914 · Cited by 1,858
Enzyme and metabolic inhibitors
Webb, J. L. (1963) · Academic Press eBooks · doi:10.5962/bhl.title.7320 · Cited by 1,514
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
(1953) · PubMed · Cited by 942
Cited by
Traditional Chinese medicine network pharmacology: theory, methodology and application
LI, S., & ZHANG, B. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60037-0 · Cited by 1,329
Self-citationCombinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
Li, S., Zhang, B., & Zhang, N. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s10 · Cited by 380
Self-citationCombined Use of Biocontrol Agents to Manage Plant Diseases in Theory and Practice
Xu, X.-M., Jeffries, P., Pautasso, M., & Jeger, M. J. (2011) · Phytopathology® · doi:10.1094/phyto-08-10-0216 · Cited by 266
Synergistic and Antagonistic Drug Combinations Depend on Network Topology
Yin, N., Ma, W., Pei, J., Ouyang, Q., Tang, C., & Lai, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093960 · Cited by 139
“[14] introduced a simplifying strategy for efficient calculation of scores representing synergistic interactions.”
Background
Metadata
- Authors
- Yan, H., Zhang, B., Li, S., & Zhao, Q.
- Affiliations
- Tsinghua University (CN)
- Corresponding author
- Li, Shao
- Zhao, Qianchuan
- Venue
- BMC Systems Biology
- Published
- 2010-04-25
- Volume
- 4
- Issue
- 1
- Pages
- 50-50
- ISSN
- 1752-0509 (ISSN-L)
- PMC
- PMC2873319
- OpenAlex
- W2165982972
- Cited by
- 73
- References
- 46
- Citations by year
- 2025: 1 · 2024: 16 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 5
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Systems Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (60934004, 60721003, 60736027)
- Project 211
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- drug synergy, NF-κB signaling, TNF-α, feedback loops, drug combination design
- MeSH terms
- Algorithms, Cells, Cultured, Chemistry, Pharmaceutical, Drug Combinations, Drug Evaluation, Preclinical, Drug Therapy, Endothelium, Vascular, Humans, Models, Biological, Models, Theoretical, Tumor Necrosis Factor-alpha, Models, Statistical, NF-kappa B, Treatment Outcome, Systems Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A formal model for analyzing drug combination effects and its application in TNF-α-induced NFκB pathway. https://app.cochat.ai/papers/10.1186/1752-0509-4-50
- The paper
- Yan, H., Zhang, B., Li, S., & Zhao, Q. (2010). A formal model for analyzing drug combination effects and its application in TNF-α-induced NFκB pathway. BMC Systems Biology. https://doi.org/10.1186/1752-0509-4-50
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.